CVS Reaches Proposed Insulin Pricing Settlement With FTC

CVS Health Corporation announced on Tuesday that it has entered into a proposed settlement agreement with the Federal Trade Commission (FTC) regarding insulin pricing. The healthcare company, which operates extensively across the United States, reached the deal following regulatory scrutiny into the costs of the life-saving medication.